Prof. Christoph Wanner is Professor of Medicine and head of the Division of Nephrology at the University Hospital of Würzburg, Germany.

He has published more than 690 scientific papers and articles on diabetic kidney disease (HF 75), lipid disorders, statin treatment and rare kidney diseases. He is steering committee member of the EMPA-REG Outcome, the EMPEROR and the EMPA-KIDNEY trials, aiming in slowing the progression of kidney disease and improving cardiovascular outcomes.

He is an Associate Editor of the Clinical Journal of the America Society of Nephrology and until this year was the Editor-in-Chief of the Journal of Renal Nutrition.

He has received the 2016 Award from the ERA-EDTA for Outstanding Clinical Contributions to Nephrology and in 2018 from the DGfN the Franz Volhard medaille, the highest awards from the German & European Societies of Nephrology.

Current Positions:

·Senior Professor of Medicine, Department of Clinical Research and Epidemiology, University Hospital of Würzburg

·Visiting Professor of Renal Medicine, Nuffield Department of Population Health, Clinical Trial Service Unit, University of Oxford, UK

Research Focus:

·Diabetic Kidney Disease, Lipid Disorders

·Published over 1000 PubMed articles, Hirsch Index (Web of Science): 116

Landmark Studies:

·The 4D Study (2005), EMPA-REG Outcome (2015&16)

Professional Leadership:

·Immediate Past President of the European Renal Association